TY - JOUR
T1 - The G-Protein–Coupled Receptor ALX/Fpr2 Regulates Adaptive Immune Responses in Mouse Submandibular Glands
AU - Wang, Ching Shuen
AU - Baker, Olga J.
N1 - Publisher Copyright:
© 2018 American Society for Investigative Pathology
PY - 2018/7
Y1 - 2018/7
N2 - Lipoxin receptor (ALX)/N-formyl peptide receptor (FPR)-2 is a G-protein–coupled receptor that has multiple binding partners, including the endogenous lipid mediators resolvin D1, lipoxin A 4 , and the Ca 2+ -dependent phospholipid-binding protein annexin A1. Previous studies have demonstrated that resolvin D1 activates ALX/Fpr2 to resolve salivary gland inflammation in the NOD/ShiLtJ mouse model of Sjögren syndrome. Moreover, mice lacking the ALX/Fpr2 display an exacerbated salivary gland inflammation in response to lipopolysaccharide. Additionally, activation of ALX/Fpr2 has been shown to be important for regulating antibody production in B cells. These previous studies indicate that ALX/Fpr2 promotes resolution of salivary gland inflammation while modulating adaptive immunity, suggesting the need for investigation of the role of ALX/Fpr2 in regulating antibody production and secretory function in mouse salivary glands. Our results indicate that aging female knockout mice lacking ALX/Fpr2 display a significant reduction in saliva flow rates and weight loss, an increased expression of autoimmune-associated genes, an up-regulation of autoantibody production, and increased CD20-positive B-cell population. Although not all effects were noted among the male knockout mice, the results nonetheless indicate that ALX/Fpr2 is clearly involved in the adaptive immunity and secretory function in salivary glands, with further investigation warranted to determine the cause(s) of these between-sex differences.
AB - Lipoxin receptor (ALX)/N-formyl peptide receptor (FPR)-2 is a G-protein–coupled receptor that has multiple binding partners, including the endogenous lipid mediators resolvin D1, lipoxin A 4 , and the Ca 2+ -dependent phospholipid-binding protein annexin A1. Previous studies have demonstrated that resolvin D1 activates ALX/Fpr2 to resolve salivary gland inflammation in the NOD/ShiLtJ mouse model of Sjögren syndrome. Moreover, mice lacking the ALX/Fpr2 display an exacerbated salivary gland inflammation in response to lipopolysaccharide. Additionally, activation of ALX/Fpr2 has been shown to be important for regulating antibody production in B cells. These previous studies indicate that ALX/Fpr2 promotes resolution of salivary gland inflammation while modulating adaptive immunity, suggesting the need for investigation of the role of ALX/Fpr2 in regulating antibody production and secretory function in mouse salivary glands. Our results indicate that aging female knockout mice lacking ALX/Fpr2 display a significant reduction in saliva flow rates and weight loss, an increased expression of autoimmune-associated genes, an up-regulation of autoantibody production, and increased CD20-positive B-cell population. Although not all effects were noted among the male knockout mice, the results nonetheless indicate that ALX/Fpr2 is clearly involved in the adaptive immunity and secretory function in salivary glands, with further investigation warranted to determine the cause(s) of these between-sex differences.
UR - http://www.scopus.com/inward/record.url?scp=85048761534&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048761534&partnerID=8YFLogxK
U2 - 10.1016/j.ajpath.2018.04.003
DO - 10.1016/j.ajpath.2018.04.003
M3 - Article
C2 - 29684359
AN - SCOPUS:85048761534
SN - 0002-9440
VL - 188
SP - 1555
EP - 1562
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 7
ER -